Psychedelic Science in 2020 | An overview of the psychedelic renaissance скачать в хорошем качестве

Psychedelic Science in 2020 | An overview of the psychedelic renaissance

🧠 Want to understand how psychedelics rewire your brain for healing and transformation? Join my free 5-day email course: Rewire Your Brain with Psychedelics → https://rewirewithpsychedelics.com Learn the science behind how psychedelics unlock neuroplasticity, enhance mental health, and create lasting change—broken down in easy to understand and practical lessons. — We are in the midst of a huge resurgence of scientific interest in psychedelic substances. They are now being shown to have great potential for a variety of applications - from treating mental conditions, to enhancing our meditation practice, to increasing our connection to nature. In this video, I give a broad overview of the latest exciting psychedelic research being conducted at leading institutions across the globe! — Follow me on Instagram for more content and to keep up with my work!   / thepsychedelicscientist   More info about me: Dr. Manesh Girn is a postdoctoral psychedelic neuroscientist working at the University California San Francisco with pioneering psychedelic researcher Dr. Robin Carhart-Harris. He conducts cutting-edge brain imaging research on the psychological and brain mechanisms underlying the psychedelic experience and psychedelic-assisted therapy. He has a PhD in Neuroscience from McGill University and has been lead or co-author on over two dozen scientific publications and book chapters on topics including psychedelics, meditation, daydreaming, and brain networks. https://www.maneshgirn.com/ Additional links:   / manesh-girn   https://scholar.google.com/citations?... --- On popular request, here are the papers I refer to in this video (in no particular order): 1. Carhart-Harris, R.L., et al., Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 2016. 3(7): p. 619-627. 2. Lyons, T. and R.L. Carhart-Harris, Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology, 2018. 32(7): p. 811-819. 3. Johnson, M.W., et al., Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & therapeutics, 2019. 197: p. 83-102. 4. Griffiths, R.R., et al., Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of psychopharmacology, 2016. 30(12): p. 1181-1197. 5. Johnson, M.W., et al., Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 2014. 28(11): p. 983-992. 6. MacLean, K.A., M.W. Johnson, and R.R. Griffiths, Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 2011. 25(11): p. 1453-1461. 7. Griffiths, R.R., et al., Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology, 2008. 22(6): p. 621-632. 8. Griffiths, R.R., et al., Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 2006. 187(3): p. 268-283. 9. Carhart-Harris, R.L. and K.J. Friston, REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacological Reviews, 2019. 71(3): p. 316-344. 10. Carhart-Harris, R.L., et al., Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences, 2016. 113(17): p. 4853-4858. 11. Carhart-Harris, R.L., et al., Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences, 2012. 109(6): p. 2138-2143. 12. Krebs, T.S. and P.-Ø. Johansen, Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 2012. 26(7): p. 994-1002. 13. Girn, M., et al., Updating the dynamic framework of thought: Creativity and psychedelics. NeuroImage, 2020: p. 116726. 14. Baggott, M.J., Psychedelics and creativity: a review of the quantitative literature. PeerJ PrePrints, 2015. 3: p. e1202v1. 15. Ross, S., et al., Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of psychopharmacology, 2016. 30(12): p. 1165-1180.